Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
PRNewswire - December 27, 2001
The experiments, conducted by OSU veterinarian Michael Podell and funded by NIH, involve giving cats methamphetamine ("speed"), a drug of abuse. Podell also infects the cats with feline immunodeficiency virus (FIV), reportedly hoping to create an "animal model" showing the brain damage known to occur in humans who are both drug abusers and infected with the AIDS virus. Podell subjects cats to spinal taps and other stressful and painful procedures before killing them to examine their brains.
PCRM is suing NIH under the Freedom of Information Act for withholding numerous details about Podell's work, including his justification for choosing cats as a suitable animal upon which to experiment, behavioral testing procedures, and his plans for removing the cats' brains. PCRM received a copy of Podell's grant application earlier this year, but NIH had removed large portions of pertinent data. The suit is being brought in the U.S. District Court for the District of Columbia.
"We believe these documents will show there is no reason to carry out these experiments on animals," says PCRM president Neal D. Barnard, M.D. "We aim to find out why NIH is spending $1.68 million on this controversial and ill-advised project. Studies of human patients have already shown the dangers of drug abuse and HIV."
PCRM argues that further research into the effects of amphetamines and HIV is more properly done in HIV-positive individuals already being treated with amphetamines for depression and in HIV-positive drug abusers. "Cats cannot show language deficits, subtle learning problems, hallucinations, delusions, or other neurological effects that are known to occur in drug abusers," Dr. Barnard says. "Moreover, the cat virus -- FIV -- is very different from HIV, and cat results would not apply to people."
Numerous critics, including neurologists, an AIDS activist organization, and a physician who specializes in drug addiction, have spoken out about the study's serious scientific shortcomings. Despite these criticisms, dozens of protests by an animal protection group in Columbus, and national news coverage, the National Institute on Drug Abuse (NIDA), a division of the NIH, recently granted Podell the second installment on his five-year, $1.68-million study.
For copies of PCRM's lawsuit and other details about this case, please contact Simon Chaitowitz, PCRM communications director, at 202-686-2210, ext. 309 or simonc@pcrm.org.
Founded in 1985, PCRM is a national health organization dedicated to promoting preventive medicine and higher standards in medical research, education, and practice. The nonprofit's membership consists of 5,000 physicians and more than 100,000 laypersons.
011227
PR011245
Copyright © 2001 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.PRNewswire.com.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .